摘要 : BackgroundCochlea sparing can reduce late ototoxicity in head and neck cancer patients treated with cisplatin-based radiochemotherapy. In this situation, amean cochlear dose (MCD) constraint of 10Gy has been suggested by others ba... 展开
作者 | Braun~ L. H. Braun~ K. Frey~ B. Wolpert~ S. M. Loewenheim~ H. Zips~ D. Welz~ S. |
---|---|
作者单位 | |
期刊名称 | 《Strahlentherapie und Onkologie》 |
总页数 | 8 |
语种/中图分类号 | 德语 / R81 |
关键词 | Organs at risk Toxicity Radiotherapy Intensity-Modulated Cisplatin Ear inner Risikoorgane Toxizitat Intensitatsmodulierte Radiotherapie Cisplatin Innenohr |
馆藏号 | N2010EPST0000648 |